UK retinitis pigmentosa research, made clearer.

Know the difference

Approved treatment is not the same as promising research.

Established: Luxturna is an approved gene therapy for eligible people with disease caused by mutations in both copies of the RPE65 gene. It is not a treatment for every form of RP.

Experimental: Every trial, grant and laboratory study shown in the live research feed should be treated as investigational unless its source explicitly says otherwise.